Samah Al Kharji

Cardiac Electrophysiologist, Chief of Department of Cardiology , AlDabbous Cardiac Center (DCC) @UTHEPHEART @CardioMcgill

[Samah Al Kharji @1sinusrhythm]

#AFib #الرجفان_الاذيني

[TCTME+ @TCT_ME_]

Desert 🥀 … we’ve rescheduled to September 17-19, 2026 🏇

[Khaled AlShaibi @drptca]

You really don’t want to miss this. An oppertunity to reconnect and foster global collaboration and highlight the standard of cardiovascular care in the region. As well as the potential within KSA for identifying med tech innovation partners and investors

[Shirefa_Alkanderii @shirefaaa]

Proud to share that our article, “EP Lab Spotlight: The Rhythm of Innovation”, has been published in the APHRS Newsletter May 2026 edition. Grateful to be part of showcasing our EP lab journey, innovation, teamwork, and growth at Al-Dabbous Cardiac Center. ⚡️📖🫀

@1sinusrhythm
@APHRSOfficial

[CardiovascularCorner @TrackYourHeart]

TP-segment downsloping on ECG strongly suggests:
A. Hyperkalemia
B. Acute pericarditis
C. Posterior MI
D. LV aneurysm

[Dr. Filippo Cademartiri @FCademartiri]

🫀💊 Lipid management after statins: more tools, more complexity, more responsibility

This 2025 JACC Advances expert panel offers a timely, pragmatic appraisal of lipid management in the post-statin era, comparing international guidelines and translating them into real-world, case-based decisions .

📌 Core message
LDL-C remains causal for ASCVD, but the therapeutic landscape has expanded dramatically. Statins are still the foundation, yet non-statin therapies are now essential to reach modern LDL-C targets—especially in high- and very-high-risk patients.

🌍 Guidelines: same evidence, different philosophies
ESC guidelines are the most aggressive (LDL-C <55 mg/dL, and <40 mg/dL after recurrent events).
ACC/AHA remain more conservative, prioritizing randomized trial evidence.
Canadian guidelines sit in between.The result? Different thresholds, same patients, increasing clinical ambiguity.
🧠 Key advances highlighted

Combination therapy beats dose escalation: doubling statins yields ~6% LDL-C reduction, while adding ezetimibe, PCSK9 inhibitors, bempedoic acid or inclisiran achieves 20–60%.
Therapeutic inertia is a major problem—many high-risk patients remain far above target.
Imaging matters: CAC ≥300 AU confers a risk similar to secondary prevention and should trigger aggressive LDL-C lowering.
Lp(a) and ApoB deserve broader screening, even if outcome-driven targets are still evolving.
👩‍⚕️ Why the case-based approach matters

Real patients rarely fit guideline boxes: young adults, women planning pregnancy, South Asian populations, HIV patients, severe hypertriglyceridemia. The paper shows how rigid guideline application fails without clinical judgment.
🔮 Bottom line

We are no longer in a “statin-only” world. Modern lipid management requires earlier risk detection, imaging-guided stratification, combination therapy, and individualized targets. Guidelines inform decisions—but expertise personalizes them 🚀

[Europace Editor-in-Chief @EuropaceEiC]

📣EHRA Document 📚
#Europace
Afib management by targeting comorbidities and reducing AF burden: the 10th AFNET/EHRA consensus conference just published 🚀
🌐https://t.co/bwPpdrkCxg

@EHRAPresident @GiulioConte9 @Dominik_Linz @AndyZhangMD @FraSantoroMD @DavideMei93 @marcovitoloMD

[AlziadiQ8 Plus | الزيادي بلس @AlziadiQ8Plus]

Video: Interview with Dr. Samah Alkharji – Discussion About arrhythmia On Good Morning Kuwait show KTV 2

https://t.co/rcrfQysBlH

[Enes Elvin Gul, MD, FESC, FEHRA @enes_elvin]

Great pleasure to join today’s LBBAP webinar and share practical insights on optimal tools and real-world implantation techniques.
Honored to be part of an excellent faculty and thankful to the organizers for this valuable educational program.
Always happy to contribute to advancing conduction system pacing.
@curilakarol @DFahadAlmehmadi @1sinusrhythm @Medtronic

[HeartRhythm @hrs_journal]

Occupational hazards in cardiac electrophysiology: Insights from an HRS member survey

https://t.co/QmwAWxDwxo

[Europace Editor-in-Chief @EuropaceEiC]

🚨#Europace #Epeeps

VT ablation vs. anti-arrhythmic drug : a meta-analysis of RCTs

✍️@FraSantoroMD et al. from @DASCAMaastricht #EHRA Course

@GiulioConte9 @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @ESC_Journals @LuigiDiBiaseMD @EHRAPresident

[Ahmed Bennis MD 🫀 @drbennisahmed]

Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study

New risk factors emerged in half of AF patients within 1.7 years. Age-specific differences underscore the need for tailored reassessment, suggesting a shorter interval of 6 months for patients ≥55 years and 1 year for those <55 years and routinely at age 65 and 75 years.

#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
@DrMarthaGulati @hvanspall @Hragy @biljana_parapid @AnastasiaSMihai @ESC_Journals @escardio
https://t.co/flvs2A9yoV

[EHRAPresident @EHRAPresident]

#EHRAtopicweek on Sustainability in EP

✅ Reusing pacemakers and catheters is:

🩺 Safe — The recent Europace #EHRA_ESC Young EP survey found that over two-thirds (67.8%) of EPs have used reprocessed materials, most viewing them as safe and cost-effective. Published studies show complication rates below 1% when reuse follows validated protocols

⚖️ Ethical — Reprocessing helps make EP procedures available to more patients, especially in regions with limited access

♻️ Sustainable — Reuse reduces costs and environmental impact by cutting waste and conserving high-value materials

🔗 https://t.co/ORY3Bu5Nds

[Shaojie Chen @ShaojieChen1]

fresh online ⚡️❄️ 🔥 ->🫀📈🧠📉

Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration)

https://t.co/e6XSUPBZdW

@EuropaceEiC @ESC_Journals @escardio @DGK_org @AGEP_DGK
@S_NarayanMD @C_Meyer_MD @Dominik_Linz @AndreasRillig @LauraPerrottaEP @KarsNeven @ChristianHeeger @MRuwald @ftrae @BA_Mulder @purerfellner @EHRAPresident @SergeBoveda @jongichun @ShaojieChen1

thank you ALL

[European Society of Cardiology Journals @ESC_Journals]

Spot the Clue: What do you see in the ECG? Challenge your colleague! https://t.co/RPX8jYROzy

A. Sinus rhythm with bigeminy premature ventricular complexes (PVC)

B. Sinus rhythm, high grade atrioventricular (AV) block with PVC

C. Sinus rhythm, premature atrial complex (PAC) with aberrant ventricular conduction

D. Sinus pause following PVC

E. Sinus bradycardia, second degree Mobitz 1 AV block, interpolated bigeminy PVCs

#EHJCaseReports @Phiso_de @TJ_Yeo @aayshacader @BoldiKovacsMD @sukritibanthiya @ANazmiCalik @O_Azizy_MD @saramoscatelli7 @EHJCREiC #CardioX #EPeeps

[Shirefa_Alkanderii @shirefaaa]

#UseHeart to take action and demand our leaders make heart health a priority this #WorldHeartDay. ❤️ Say YES to healthier hearts everywhere: https://t.co/QxfPrBOVW8. #HeartYes https://t.co/CBmFwv6OQ9

[Samah Al Kharji @1sinusrhythm]

@GULFHeartAssoc

[Samah Al Kharji @1sinusrhythm]

Join us at the 17th Gulf Heart Association Conference on November 20-22 in Doha, Qatar!

Register using : https://t.co/bhKbYukEjA

[European Society of Cardiology Journals @ESC_Journals]

📢 New publication in ESC Heart Failure: "Epicardial, visceral and subcutaneous adipose tissue in heart failure with preserved ejection fraction". 👉 https://t.co/PyvyLS2ksm

#HFpEF #HeartFailure #ESCHeartFailure #HFA_ESC @EJHFEiC @JanBiegus @Ppponikowski @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @MarcoMetra @GianluSava

[Raviele Antonio @drraviele]

WITHDRAW-AF RCT
📌 In👫w/ presumed AF-induced #cardiomyopathy &amp; normalized #LVEF after SR restoration
👉 withdrawal of #HF therapy is not assoc w/ LVEF ⬇️ again in 90% of👫in the following 6-m
#EPeeps #afib #HeartFailure #CardioTwitter #MedTwitter @DrMarthaGulati @JagSinghMD

[إبراهيم الحربي Ibrahim Alharbi @Dr_ibrahimHarbi]

My Takeaways from #ESCCongress2025 #LBCT
Followed remotely, Thnx to those who spread this huge knowledge globally🫀#ESCCongress #ESC2025 #CardioEd